HIV Prevention Research & Development Investments 2018: Investing to end the epidemic

This annual accounting of funding for biomedical HIV prevention research tracks trends and identifies gaps in investment. The report indicates an uptick after five consecutive years of declining investment. In 2018, funding for HIV prevention R&D increased by a modest 1.2 percent or US$13 million from the previous year, growing to US$1.14 billion. While the increase is encouraging, it’s the smallest net increase since 2003.

Click here for the full archive of past resource tracking reports.

Tracking and Translating the Field